帕金森病的营养:神经学家需要知道什么
Marshal Spenser Shuler1, Aakash Prasad1, Richelle Flanagan2
1Liggins Institute, University of Auckland, Auckland, New Zealand.
Practical neurology
|January 27, 2026
概括
这篇评论提供了最新的帕金森氏症,帕金森氏症.
科学领域:
- 神经学 神经学
- 营养科学 营养科学
- 临床医学 临床医学
背景情况:
- 最佳营养对整体健康至关重要.
- 帕金森病 (PD) 的非运动性症状显著影响营养状况.
- 现有的临床营养指南缺乏PD特定的饮食建议.
研究的目的:
- 为神经科医生提供最新的PD特定饮食指南.
- 在帕金森病管理中提供关键营养考虑的简要概述.
- 为了解决PD患者营养状况的挑战.
主要方法:
- 对帕金森病当前营养建议的文献综述.
- 综合有关PD特定营养挑战和策略的证据.
- 专注于临床应用的实际指导.
主要成果:
- 关键的营养领域包括体重调节和微量营养素管理.
- 讨论了优化蛋白质摄入量的策略,同时最大限度地减少药物相互作用.
- 概述了胃肠道问题和症状管理的饮食方法.
结论:
- 更新,PD特定的营养指南对于改善患者的治疗结果至关重要.
- 解决营养状况是帕金森病综合护理的组成部分.
- 本综述支持临床医生管理PD患者复杂的营养需求.
关键词:
帕金森氏症的疾病相关概念视频
Neural Regulation
34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Chronic Kidney Disease III: Interprofessional Care
679
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679
Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28


